공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 3D 바이오프린팅 시장(2019-2025년)

Global 3D Bioprinting Market 2019-2025

리서치사 Orion Market Research Pvt Ltd
발행일 2019년 12월 상품 코드 920447
페이지 정보 영문
가격
US $ 3,600 ₩ 4,005,000 Unprintable PDF (Single User License)
US $ 4,800 ₩ 5,340,000 Printable PDF (Enterprise License)


세계의 3D 바이오프린팅 시장(2019-2025년) Global 3D Bioprinting Market 2019-2025
발행일 : 2019년 12월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 3D 바이오프린팅 시장은 예측기간 중 크게 성장할 것으로 예상됩니다. 시장 성장에 기여하는 주요 요인은 생활 습관병의 발생 비율 상승, 장기 및 조직 이식의 대규모 수요 등이 있습니다. 예를 들어 미국의 보건자원서비스국(HRSA)에 따르면, 2018년에는 36,528건의 장기 이식이 이루어졌습니다. 2018년 1월 현재 113,000명 이상이 장기 이식을 기다리고 있습니다. 제한된 수의 장기 기증자도 3D 바이오프린팅 시장의 성장에 기여하고 있습니다. 미국 보건복지부에 따르면 10분당 전국 이식 대기자 명단에 이름이 추가되고 있습니다. 이식 대기자 명단이 증가함에 따라 3D 바이오프린트 임플란트 및 장기의 가능성이 발생하고 있습니다.

세계의 3D 바이오프린팅(3D Bioprinting) 시장에 대해 조사 분석했으며, 시장 개요, 시장 결정요인, 시장 세분화, 경쟁 상황, 지역별 분석, 주요 기업 등에 대한 체계적인 정보를 제공합니다.

목차

제1장 보고서 개요

  • 조사 방법과 수단
  • 시장 분석
    • 부문별
    • 지역별

제2장 시장 개요와 인사이트

  • 보고서의 범위
  • 애널리스트의 견해와 최신 시장 동향
    • 주요 조사 결과
    • 제안
    • 결론
  • 규칙 및 규제

제3장 경쟁 상황

  • 기업 점유율 분석
  • 주요 전략 분석
  • 주요 기업 분석
    • 3D Systems Corp.
    • Organovo Holdings, Inc
    • CELLINK AB
    • CollPlant Ltd.
    • Stratasys Ltd.

제4장 시장 결정요인

  • 성장 촉진요인
  • 성장 저해요인
  • 시장 기회

제5장 시장 세분화

  • 기술별 시장
    • 압출 기반
    • 레이저 기반
    • 잉크젯 기반
    • 기타(마이크로밸브 기반 및 스테레오리소그래피 기반)
  • 용도별 시장
    • 약물 검사 및 개발
    • 3D 세포 배양
    • 조직 및 장기 재생
    • 기타(식품 시험)

제6장 지역 분석

  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 영국
    • 독일
    • 이탈리아
    • 스페인
    • 프랑스
    • 기타
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 기타
  • 기타 지역

제7장 기업 개요

  • 3D Bioprinting Solutions
  • 3D Systems Corp.
  • Advanced BioMatrix, Inc.
  • Aleph Objects, Inc.
  • Allevi
  • Aspect Biosystems Ltd.
  • CELLINK AB
  • CollPlant Ltd.
  • Cyfuse Biomedical KK
  • Digilab, Inc.
  • EnvisionTEC, Inc.
  • Formlabs Inc.
  • GeSiM GmbH
  • Materialise NV
  • Medprin Biotech GmbH
  • Nano3D Biosciences, Inc.
  • Organovo Holdings Inc.
  • Poietis
  • REGEMAT 3D SL
  • regenHU Ltd.
  • Regenovo Biotechnology Co., Ltd.
  • Stratasys, Ltd.
  • United Therapeutics Corp.
KSM 20.01.30

List of Tables

  • 1. GLOBAL 3D BIOPRINTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)
  • 2. GLOBAL EXTRUSION-BASED 3D BIOPRINTING MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 3. GLOBAL LASER-BASED 3D BIOPRINTING MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 4. GLOBAL INKJET-BASED 3D BIOPRINTING MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 5. GLOBAL OTHER 3D BIOPRINTING TECHNOLOGIES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 6. GLOBAL 3D BIOPRINTING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
  • 7. GLOBAL 3D BIOPRINTING FOR DRUG TESTING AND DEVELOPMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 8. GLOBAL 3D BIOPRINTING FOR 3D CELL CULTURE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 9. GLOBAL 3D BIOPRINTING FOR TISSUE AND ORGAN REGENERATION MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 10. GLOBAL 3D BIOPRINTING FOR OTHER APPLICATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 11. GLOBAL 3D BIOPRINTING MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)
  • 12. NORTH AMERICAN 3D BIOPRINTING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 13. NORTH AMERICAN 3D BIOPRINTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)
  • 14. NORTH AMERICAN 3D BIOPRINTING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
  • 15. EUROPEAN 3D BIOPRINTING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 16. EUROPEAN 3D BIOPRINTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)
  • 17. EUROPEAN 3D BIOPRINTING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
  • 18. ASIA-PACIFIC 3D BIOPRINTING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 19. ASIA-PACIFIC 3D BIOPRINTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)
  • 20. ASIA-PACIFIC 3D BIOPRINTING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
  • 21. REST OF THE WORLD 3D BIOPRINTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)
  • 22. REST OF THE WORLD 3D BIOPRINTING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)

List of Figures

  • 1. GLOBAL 3D BIOPRINTING MARKET SHARE BY TECHNOLOGY, 2018 VS 2025 (%)
  • 2. GLOBAL 3D BIOPRINTING MARKET SHARE BY APPLICATION, 2018 VS 2025 (%)
  • 3. GLOBAL 3D BIOPRINTING MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)
  • 4. US 3D BIOPRINTING MARKET SIZE, 2018-2025 ($ MILLION)
  • 5. CANADA 3D BIOPRINTING MARKET SIZE, 2018-2025 ($ MILLION)
  • 6. UK 3D BIOPRINTING MARKET SIZE, 2018-2025 ($ MILLION)
  • 7. FRANCE 3D BIOPRINTING MARKET SIZE, 2018-2025 ($ MILLION)
  • 8. GERMANY 3D BIOPRINTING MARKET SIZE, 2018-2025 ($ MILLION)
  • 9. ITALY 3D BIOPRINTING MARKET SIZE, 2018-2025 ($ MILLION)
  • 10. SPAIN 3D BIOPRINTING MARKET SIZE, 2018-2025 ($ MILLION)
  • 11. ROE 3D BIOPRINTING MARKET SIZE, 2018-2025 ($ MILLION)
  • 12. INDIA 3D BIOPRINTING MARKET SIZE, 2018-2025 ($ MILLION)
  • 13. CHINA 3D BIOPRINTING MARKET SIZE, 2018-2025 ($ MILLION)
  • 14. JAPAN 3D BIOPRINTING MARKET SIZE, 2018-2025 ($ MILLION)
  • 15. REST OF ASIA-PACIFIC 3D BIOPRINTING MARKET SIZE, 2018-2025 ($ MILLION)
  • 16. REST OF THE WORLD 3D BIOPRINTING MARKET SIZE, 2018-2025 ($ MILLION)

3D Bioprinting Market Size, Share & Trends Analysis Report, By Technology (Extrusion-Based, Laser-Based, Inkjet-Based and Others), By Application (Drug Testing and Development, 3D Cell Culture, Tissue and Organ Regeneration, and Others) and Forecast 2019-2025

The global 3D bioprinting market is anticipated to grow at a significant rate during the forecast period. The major factors contributing to the growth of the market include rising incidences of lifestyle-oriented diseases and massive demand for organ & tissue transplants. For instance, as per the Health Resources and Services Administration (HRSA), in the US, 36,528 organ transplants were performed in 2018. As of January 2018, more than 113,000 people are waiting for organ transplantation. A limited number of organ donors has also contributed towards the growth of the 3D bioprinting market. According to the US Department of Health & Human Services, in every 10 minutes, an individual is added to the national transplant waiting list. The growth in the waiting list of transplants has created a potential for the 3D bio-printed implants and organs.

The global 3D bioprinting market is segmented on the basis of technology and application. On the basis of technology, the market is segmented into extrusion-based, laser-based, inkjet-based and others. Extrusion-based technology is expected to hold a significant share in the global 3D bioprinting market. Further, on the basis of application, the market is segmented into drug testing and development, 3D cell culture, tissue and organ regeneration, and others. Drug testing and development is expected to contribute significantly to the growth of the market.

The global 3D bioprinting market geographically covers the analysis of four major regions; North America (the US and Canada), Europe (Germany, UK, France, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, India, and Rest of Asia-Pacific), and RoW. North America dominated the global 3D bioprinting market in 2018. A rise in the demand for organ transplantation along with reasonably higher patient disposable income and sophisticated healthcare infrastructure are some of the key drivers for the regional growth of the market.

Moreover, the market is fragmented in nature with the presence of several players. Some of the key players operating in the market include Organovo Holdings, Inc., 3D Systems Corp., CELLINK AB, Stratasys Ltd., and CollPlant Ltd. The market players are teaming up with universities and research institutes that work on grafting as well as organ regeneration technologies. In 2015, Organovo Holding Inc. participated in Cantor Fitzgerald Inaugural Healthcare Conference with an aim to increase awareness related to their current activities in 3D bioprinting market.

Research Methodology

The market study of the global 3D bioprinting market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity in our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market.
  • Authentic public databases
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report is intended for 3D bioprinting manufacturers, suppliers, and distributors, cosmetic product manufacturers, suppliers, and distributors, pharmaceutical and biotechnology companies, healthcare organizations, medical research laboratories, academic and research institutes, and government organizations for overall market analysis and competitive analysis. The report provides in-depth analysis on market size, products offered by the companies, and future market opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for making better market decisions.

Market Segmentation:

1. Global 3D Bioprinting Market Research and Analysis, By Technology

2. Global 3D Bioprinting Market Research and Analysis, By Application

The Report covers:

  • Comprehensive research methodology of the global 3D bioprinting market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global 3D bioprinting market.
  • Insights about market determinants which are stimulating the global 3D bioprinting market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Company Share Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. 3D Systems Corp.
      • 3.3.1.1. Overview
      • 3.3.1.2. Financial Analysis
      • 3.3.1.3. SWOT Analysis
      • 3.3.1.4. Recent Developments
    • 3.3.2. Organovo Holdings, Inc.
      • 3.3.2.1. Overview
      • 3.3.2.2. Financial Analysis
      • 3.3.2.3. SWOT Analysis
      • 3.3.2.4. Recent Developments
    • 3.3.3. CELLINK AB
      • 3.3.3.1. Overview
      • 3.3.3.2. Financial Analysis
      • 3.3.3.3. SWOT Analysis
      • 3.3.3.4. Recent Developments
    • 3.3.4. CollPlant Ltd.
      • 3.3.4.1. Overview
      • 3.3.4.2. Financial Analysis
      • 3.3.4.3. SWOT Analysis
      • 3.3.4.4. Recent Developments
    • 3.3.5. Stratasys Ltd.
      • 3.3.5.1. Overview
      • 3.3.5.2. Financial Analysis
      • 3.3.5.3. SWOT Analysis
      • 3.3.5.4. Recent Developments

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global 3D Bioprinting Market by Technology
    • 5.1.1. Extrusion-based
    • 5.1.2. Laser-based
    • 5.1.3. Inkjet-based
    • 5.1.4. Others (Microvalve-based and Stereolithography-based)
  • 5.2. Global 3D Bioprinting Market by Application
    • 5.2.1. Drug Testing and Development
    • 5.2.2. 3D Cell Culture
    • 5.2.3. Tissue and Organ Regeneration
    • 5.2.4. Others (Food Testing)

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. 3D Bioprinting Solutions
  • 7.2. 3D Systems Corp.
  • 7.3. Advanced BioMatrix, Inc.
  • 7.4. Aleph Objects, Inc.
  • 7.5. Allevi
  • 7.6. Aspect Biosystems Ltd.
  • 7.7. CELLINK AB
  • 7.8. CollPlant Ltd.
  • 7.9. Cyfuse Biomedical KK
  • 7.10. Digilab, Inc.
  • 7.11. EnvisionTEC, Inc.
  • 7.12. Formlabs Inc.
  • 7.13. GeSiM GmbH
  • 7.14. Materialise NV
  • 7.15. Medprin Biotech GmbH
  • 7.16. Nano3D Biosciences, Inc.
  • 7.17. Organovo Holdings Inc.
  • 7.18. Poietis
  • 7.19. REGEMAT 3D S.L.
  • 7.20. regenHU Ltd.
  • 7.21. Regenovo Biotechnology Co., Ltd.
  • 7.22. Stratasys, Ltd.
  • 7.23. United Therapeutics Corp.
Back to Top
전화 문의
F A Q